Literature DB >> 22086186

Influence of dendrimers on red blood cells.

Barbara Ziemba1, Gabriela Matuszko, Maria Bryszewska, Barbara Klajnert.   

Abstract

Dendrimers, highly branched macromolecules with a specific size and shape, provide many exciting opportunities for biomedical applications. However, most dendrimers demonstrate toxic and haemolytic activity because of their positively charged surface. Masking the peripheral cationic groups by coating them with biocompatible molecules is a method to reduce it. It was proven that modified dendrimers can even diminish haemolytic activity of encapsulated drugs. Experiments confirmed that anionic dendrimers are less haemotoxic than cationic ones. Due to the high affinity of dendrimers for serum proteins, presence of these components in an incubation buffer might also influence red blood cell (RBC)-dendrimer interactions and decrease the haemolysis level. Generally, haemotoxicity of dendrimers is concentration-, generation-, and time-dependent. Various changes in the RBCs' shape in response to interactions with dendrimers have been observed, from echinocytic transformations through cell aggregation to cluster formation, depending on the dendrimer's type and concentration. Understanding the physical and chemical origins of dendrimers' influences on RBCs might advance scientists' ability to construct dendrimers more suitable for medical applications.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22086186      PMCID: PMC6275740          DOI: 10.2478/s11658-011-0033-9

Source DB:  PubMed          Journal:  Cell Mol Biol Lett        ISSN: 1425-8153            Impact factor:   5.787


  44 in total

1.  Preliminary evaluation of the behavior of fifth-generation thiophosphate dendrimer in biological systems.

Authors:  Dariusz M Domański; Maria Bryszewska; Grzegorz Salamończyk
Journal:  Biomacromolecules       Date:  2004 Sep-Oct       Impact factor: 6.988

2.  Influence of polyethylene glycol chain length on the physicochemical and biological properties of poly(ethylene imine)-graft-poly(ethylene glycol) block copolymer/SiRNA polyplexes.

Authors:  Shirui Mao; Michael Neu; Oliver Germershaus; Olivia Merkel; Johannes Sitterberg; Udo Bakowsky; Thomas Kissel
Journal:  Bioconjug Chem       Date:  2006 Sep-Oct       Impact factor: 4.774

3.  Temperature-sensitive pluronic/poly(ethylenimine) nanocapsules for thermally triggered disruption of intracellular endosomal compartment.

Authors:  Seung Ho Choi; Soo Hyeon Lee; Tae Gwan Park
Journal:  Biomacromolecules       Date:  2006-06       Impact factor: 6.988

4.  High-generation polycationic dendrimers are unusually effective at disrupting anionic vesicles: membrane bending model.

Authors:  Z Y Zhang; B D Smith
Journal:  Bioconjug Chem       Date:  2000 Nov-Dec       Impact factor: 4.774

5.  Influence of PAMAM dendrimers on human red blood cells.

Authors:  D M Domański; B Klajnert; M Bryszewska
Journal:  Bioelectrochemistry       Date:  2004-06       Impact factor: 5.373

6.  Lipid bilayer curvature and pore formation induced by charged linear polymers and dendrimers: the effect of molecular shape.

Authors:  Hwankyu Lee; Ronald G Larson
Journal:  J Phys Chem B       Date:  2008-09-04       Impact factor: 2.991

7.  The influence of densely organized maltose shells on the biological properties of poly(propylene imine) dendrimers: new effects dependent on hydrogen bonding.

Authors:  Barbara Klajnert; Dietmar Appelhans; Hartmut Komber; Nina Morgner; Simona Schwarz; Sven Richter; Bernhard Brutschy; Maksim Ionov; Anatoly K Tonkikh; Maria Bryszewska; Brigitte Voit
Journal:  Chemistry       Date:  2008       Impact factor: 5.236

8.  The influence of surface modification on the cytotoxicity of PAMAM dendrimers.

Authors:  R Jevprasesphant; J Penny; R Jalal; D Attwood; N B McKeown; A D'Emanuele
Journal:  Int J Pharm       Date:  2003-02-18       Impact factor: 5.875

9.  In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis.

Authors:  Dagmar Fischer; Youxin Li; Barbara Ahlemeyer; Josef Krieglstein; Thomas Kissel
Journal:  Biomaterials       Date:  2003-03       Impact factor: 12.479

Review 10.  Dendrimer nanocarriers as versatile vectors in gene delivery.

Authors:  Tathagata Dutta; Narendra K Jain; Nigel A J McMillan; Harendra S Parekh
Journal:  Nanomedicine       Date:  2009-05-18       Impact factor: 5.307

View more
  11 in total

Review 1.  Leveraging the interplay of nanotechnology and neuroscience: Designing new avenues for treating central nervous system disorders.

Authors:  Elizabeth S Smith; Joshua E Porterfield; Rangaramanujam M Kannan
Journal:  Adv Drug Deliv Rev       Date:  2019-03-04       Impact factor: 15.470

Review 2.  PEGylation as a strategy for improving nanoparticle-based drug and gene delivery.

Authors:  Jung Soo Suk; Qingguo Xu; Namho Kim; Justin Hanes; Laura M Ensign
Journal:  Adv Drug Deliv Rev       Date:  2015-10-09       Impact factor: 15.470

Review 3.  Pre-clinical immunotoxicity studies of nanotechnology-formulated drugs: Challenges, considerations and strategy.

Authors:  Marina A Dobrovolskaia
Journal:  J Control Release       Date:  2015-09-05       Impact factor: 9.776

4.  A study on the hemocompatibility of dendronized chitosan derivatives in red blood cells.

Authors:  Yanfang Zhou; Jiemei Li; Fang Lu; Junjie Deng; Jiahua Zhang; Peijie Fang; Xinsheng Peng; Shu-Feng Zhou
Journal:  Drug Des Devel Ther       Date:  2015-05-14       Impact factor: 4.162

5.  In vitro toxicity studies of biodegradable, polyelectrolyte nanocapsules.

Authors:  Alicja Karabasz; Krzysztof Szczepanowicz; Agnieszka Cierniak; Joanna Bereta; Monika Bzowska
Journal:  Int J Nanomedicine       Date:  2018-09-06

Review 6.  Immunotoxicity Considerations for Next Generation Cancer Nanomedicines.

Authors:  Gary Hannon; Joanne Lysaght; Neill J Liptrott; Adriele Prina-Mello
Journal:  Adv Sci (Weinh)       Date:  2019-08-01       Impact factor: 16.806

7.  Synthesis and Characterization of FITC Labelled Ruthenium Dendrimer as a Prospective Anticancer Drug.

Authors:  Sylwia Michlewska; Małgorzata Kubczak; Marta Maroto-Díaz; Natalia Sanz Del Olmo; Paula Ortega; Dzmitry Shcharbin; Rafael Gomez Ramirez; Francisco Javier de la Mata; Maksim Ionov; Maria Bryszewska
Journal:  Biomolecules       Date:  2019-08-25

8.  Molecularly targeted nanoparticles: an emerging tool for evaluation of expression of the receptor for advanced glycation end products in a murine model of peripheral artery disease.

Authors:  Marcin Woźniak; Christian J Konopka; Agata Płoska; Jamila Hedhli; Anna Siekierzycka; Maciej Banach; Rafal Bartoszewski; Lawrence W Dobrucki; Leszek Kalinowski; Iwona T Dobrucki
Journal:  Cell Mol Biol Lett       Date:  2021-03-16       Impact factor: 5.787

Review 9.  Recent Advances in Nanoplatforms for the Treatment of Osteosarcoma.

Authors:  Kunzhe Wu; Beibei Yu; Di Li; Yangyang Tian; Yan Liu; Jinlan Jiang
Journal:  Front Oncol       Date:  2022-02-15       Impact factor: 6.244

Review 10.  Nanodrugs: pharmacokinetics and safety.

Authors:  Satomi Onoue; Shizuo Yamada; Hak-Kim Chan
Journal:  Int J Nanomedicine       Date:  2014-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.